nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CHRM1—schizophrenia	0.247	0.307	CbGaD
Escitalopram—SLC6A3—schizophrenia	0.176	0.218	CbGaD
Escitalopram—HTR2C—schizophrenia	0.159	0.197	CbGaD
Escitalopram—SLC6A4—schizophrenia	0.131	0.163	CbGaD
Escitalopram—CYP2D6—schizophrenia	0.0923	0.115	CbGaD
Escitalopram—SLC6A2—locus ceruleus—schizophrenia	0.00714	0.11	CbGeAlD
Escitalopram—SLC6A3—telencephalic ventricle—schizophrenia	0.0042	0.0646	CbGeAlD
Escitalopram—HTR2C—telencephalic ventricle—schizophrenia	0.00406	0.0625	CbGeAlD
Escitalopram—SLC6A2—autonomic nervous system—schizophrenia	0.00379	0.0584	CbGeAlD
Escitalopram—CYP2C19—urine—schizophrenia	0.00291	0.0448	CbGeAlD
Escitalopram—Citalopram—CHRM1—schizophrenia	0.0019	0.249	CrCbGaD
Escitalopram—SLC6A4—blood plasma—schizophrenia	0.00183	0.0282	CbGeAlD
Escitalopram—CYP3A4—urine—schizophrenia	0.00172	0.0265	CbGeAlD
Escitalopram—CYP2D6—urine—schizophrenia	0.00169	0.0261	CbGeAlD
Escitalopram—CYP2C19—blood plasma—schizophrenia	0.00152	0.0234	CbGeAlD
Escitalopram—Citalopram—SLC6A3—schizophrenia	0.00135	0.177	CrCbGaD
Escitalopram—Citalopram—HTR2C—schizophrenia	0.00122	0.16	CrCbGaD
Escitalopram—SLC6A3—forebrain—schizophrenia	0.0011	0.0169	CbGeAlD
Escitalopram—HTR2C—forebrain—schizophrenia	0.00106	0.0163	CbGeAlD
Escitalopram—Citalopram—SLC6A4—schizophrenia	0.00101	0.133	CrCbGaD
Escitalopram—SLC6A3—telencephalon—schizophrenia	0.00101	0.0155	CbGeAlD
Escitalopram—SLC6A4—forebrain—schizophrenia	0.001	0.0155	CbGeAlD
Escitalopram—CHRM1—forebrain—schizophrenia	0.001	0.0154	CbGeAlD
Escitalopram—HTR2C—telencephalon—schizophrenia	0.000974	0.015	CbGeAlD
Escitalopram—SLC6A4—telencephalon—schizophrenia	0.000923	0.0142	CbGeAlD
Escitalopram—CHRM1—telencephalon—schizophrenia	0.00092	0.0142	CbGeAlD
Escitalopram—Citalopram—CYP1A2—schizophrenia	0.00092	0.121	CrCbGaD
Escitalopram—CYP3A4—blood plasma—schizophrenia	0.000898	0.0138	CbGeAlD
Escitalopram—SLC6A2—forebrain—schizophrenia	0.000884	0.0136	CbGeAlD
Escitalopram—CYP2D6—blood plasma—schizophrenia	0.000883	0.0136	CbGeAlD
Escitalopram—ADRA1A—forebrain—schizophrenia	0.000822	0.0127	CbGeAlD
Escitalopram—SLC6A2—telencephalon—schizophrenia	0.000813	0.0125	CbGeAlD
Escitalopram—ADRA1A—telencephalon—schizophrenia	0.000756	0.0116	CbGeAlD
Escitalopram—SLC6A3—midbrain—schizophrenia	0.000723	0.0111	CbGeAlD
Escitalopram—Citalopram—CYP2D6—schizophrenia	0.00071	0.0932	CrCbGaD
Escitalopram—HTR2C—midbrain—schizophrenia	0.000699	0.0108	CbGeAlD
Escitalopram—SLC6A2—gonad—schizophrenia	0.000678	0.0105	CbGeAlD
Escitalopram—SLC6A4—blood—schizophrenia	0.000671	0.0103	CbGeAlD
Escitalopram—SLC6A4—midbrain—schizophrenia	0.000663	0.0102	CbGeAlD
Escitalopram—HRH1—forebrain—schizophrenia	0.000636	0.0098	CbGeAlD
Escitalopram—SLC6A3—nervous system—schizophrenia	0.000595	0.00916	CbGeAlD
Escitalopram—HRH1—telencephalon—schizophrenia	0.000585	0.00901	CbGeAlD
Escitalopram—SLC6A4—endocrine gland—schizophrenia	0.000582	0.00897	CbGeAlD
Escitalopram—CHRM1—endocrine gland—schizophrenia	0.00058	0.00894	CbGeAlD
Escitalopram—HTR2C—nervous system—schizophrenia	0.000575	0.00886	CbGeAlD
Escitalopram—SLC6A3—central nervous system—schizophrenia	0.000573	0.00882	CbGeAlD
Escitalopram—SLC6A3—cerebellum—schizophrenia	0.00056	0.00862	CbGeAlD
Escitalopram—CYP2C19—blood—schizophrenia	0.000556	0.00857	CbGeAlD
Escitalopram—HTR2C—central nervous system—schizophrenia	0.000553	0.00853	CbGeAlD
Escitalopram—ADRA1A—blood—schizophrenia	0.000549	0.00847	CbGeAlD
Escitalopram—SLC6A4—nervous system—schizophrenia	0.000545	0.0084	CbGeAlD
Escitalopram—CHRM1—nervous system—schizophrenia	0.000543	0.00837	CbGeAlD
Escitalopram—SLC6A4—central nervous system—schizophrenia	0.000525	0.00808	CbGeAlD
Escitalopram—CHRM1—central nervous system—schizophrenia	0.000523	0.00805	CbGeAlD
Escitalopram—SLC6A2—endocrine gland—schizophrenia	0.000513	0.0079	CbGeAlD
Escitalopram—Citalopram—ABCB1—schizophrenia	0.000507	0.0665	CrCbGaD
Escitalopram—CYP2D6—forebrain—schizophrenia	0.000484	0.00746	CbGeAlD
Escitalopram—CYP2C19—endocrine gland—schizophrenia	0.000482	0.00743	CbGeAlD
Escitalopram—SLC6A2—nervous system—schizophrenia	0.00048	0.00739	CbGeAlD
Escitalopram—ADRA1A—endocrine gland—schizophrenia	0.000477	0.00734	CbGeAlD
Escitalopram—SLC6A2—central nervous system—schizophrenia	0.000462	0.00712	CbGeAlD
Escitalopram—SLC6A3—brain—schizophrenia	0.000455	0.007	CbGeAlD
Escitalopram—ADRA1A—nervous system—schizophrenia	0.000446	0.00687	CbGeAlD
Escitalopram—CYP2D6—telencephalon—schizophrenia	0.000445	0.00686	CbGeAlD
Escitalopram—HTR2C—brain—schizophrenia	0.000439	0.00677	CbGeAlD
Escitalopram—ADRA1A—central nervous system—schizophrenia	0.000429	0.00662	CbGeAlD
Escitalopram—ADRA1A—cerebellum—schizophrenia	0.00042	0.00647	CbGeAlD
Escitalopram—SLC6A4—brain—schizophrenia	0.000417	0.00642	CbGeAlD
Escitalopram—CHRM1—brain—schizophrenia	0.000415	0.00639	CbGeAlD
Escitalopram—HRH1—endocrine gland—schizophrenia	0.000369	0.00568	CbGeAlD
Escitalopram—SLC6A2—brain—schizophrenia	0.000367	0.00565	CbGeAlD
Escitalopram—HRH1—nervous system—schizophrenia	0.000345	0.00532	CbGeAlD
Escitalopram—ADRA1A—brain—schizophrenia	0.000341	0.00525	CbGeAlD
Escitalopram—HRH1—central nervous system—schizophrenia	0.000332	0.00512	CbGeAlD
Escitalopram—CYP3A4—blood—schizophrenia	0.000329	0.00507	CbGeAlD
Escitalopram—CYP2D6—blood—schizophrenia	0.000324	0.00499	CbGeAlD
Escitalopram—CYP3A4—endocrine gland—schizophrenia	0.000285	0.0044	CbGeAlD
Escitalopram—CYP2D6—endocrine gland—schizophrenia	0.000281	0.00432	CbGeAlD
Escitalopram—CYP3A4—nervous system—schizophrenia	0.000267	0.00411	CbGeAlD
Escitalopram—HRH1—brain—schizophrenia	0.000264	0.00407	CbGeAlD
Escitalopram—CYP2D6—nervous system—schizophrenia	0.000263	0.00405	CbGeAlD
Escitalopram—CYP3A4—central nervous system—schizophrenia	0.000257	0.00396	CbGeAlD
Escitalopram—CYP2D6—central nervous system—schizophrenia	0.000253	0.0039	CbGeAlD
Escitalopram—CYP2D6—cerebellum—schizophrenia	0.000247	0.00381	CbGeAlD
Escitalopram—CYP2D6—brain—schizophrenia	0.000201	0.00309	CbGeAlD
Escitalopram—HRH1—Signaling Pathways—TLE3—schizophrenia	1.37e-05	0.000112	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TLE3—schizophrenia	1.36e-05	0.000111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PLA2G4A—schizophrenia	1.36e-05	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLCH2—schizophrenia	1.34e-05	0.00011	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TLE3—schizophrenia	1.34e-05	0.00011	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGA—schizophrenia	1.33e-05	0.000109	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR2A—schizophrenia	1.33e-05	0.000108	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP26B1—schizophrenia	1.33e-05	0.000108	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NPY—schizophrenia	1.3e-05	0.000106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ATP2A2—schizophrenia	1.3e-05	0.000106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOTCH4—schizophrenia	1.3e-05	0.000106	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCK—schizophrenia	1.29e-05	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCK—schizophrenia	1.29e-05	0.000105	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPH1—schizophrenia	1.28e-05	0.000105	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCLM—schizophrenia	1.28e-05	0.000105	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCK—schizophrenia	1.27e-05	0.000104	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NDST3—schizophrenia	1.26e-05	0.000103	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PDE4B—schizophrenia	1.26e-05	0.000103	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PDE4B—schizophrenia	1.26e-05	0.000102	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR1B—schizophrenia	1.25e-05	0.000102	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OXT—schizophrenia	1.25e-05	0.000102	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCKAR—schizophrenia	1.24e-05	0.000101	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PDE4B—schizophrenia	1.24e-05	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCKAR—schizophrenia	1.24e-05	0.000101	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCKAR—schizophrenia	1.22e-05	9.92e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.21e-05	9.88e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PRKD1—schizophrenia	1.21e-05	9.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR2A—schizophrenia	1.21e-05	9.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR1A—schizophrenia	1.2e-05	9.82e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADORA2A—schizophrenia	1.2e-05	9.81e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ACSL6—schizophrenia	1.2e-05	9.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC27A5—schizophrenia	1.2e-05	9.78e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADORA2A—schizophrenia	1.2e-05	9.77e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NPS—schizophrenia	1.19e-05	9.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PLA2G4A—schizophrenia	1.18e-05	9.64e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPH1—schizophrenia	1.18e-05	9.64e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCLM—schizophrenia	1.18e-05	9.64e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADORA2A—schizophrenia	1.18e-05	9.62e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PLA2G4A—schizophrenia	1.18e-05	9.61e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD1—schizophrenia	1.16e-05	9.48e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PLA2G4A—schizophrenia	1.16e-05	9.46e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGA—schizophrenia	1.15e-05	9.4e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2A—schizophrenia	1.15e-05	9.4e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGA—schizophrenia	1.15e-05	9.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2A—schizophrenia	1.15e-05	9.37e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DAO—schizophrenia	1.14e-05	9.33e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGA—schizophrenia	1.13e-05	9.23e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NTRK2—schizophrenia	1.13e-05	9.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2A—schizophrenia	1.13e-05	9.22e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD3—schizophrenia	1.13e-05	9.18e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NPY—schizophrenia	1.12e-05	9.16e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOTCH4—schizophrenia	1.12e-05	9.16e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ATP2A2—schizophrenia	1.12e-05	9.16e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NPY—schizophrenia	1.12e-05	9.13e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOTCH4—schizophrenia	1.12e-05	9.13e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ATP2A2—schizophrenia	1.12e-05	9.13e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PRKD1—schizophrenia	1.11e-05	9.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NPY—schizophrenia	1.1e-05	8.99e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOTCH4—schizophrenia	1.1e-05	8.99e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ATP2A2—schizophrenia	1.1e-05	8.99e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PNP—schizophrenia	1.1e-05	8.94e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD4—schizophrenia	1.09e-05	8.92e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OXT—schizophrenia	1.08e-05	8.84e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR1B—schizophrenia	1.08e-05	8.84e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OXT—schizophrenia	1.08e-05	8.81e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR1B—schizophrenia	1.08e-05	8.81e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR1B—schizophrenia	1.06e-05	8.67e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OXT—schizophrenia	1.06e-05	8.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2A—schizophrenia	1.05e-05	8.53e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CNR1—schizophrenia	1.04e-05	8.51e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR1A—schizophrenia	1.04e-05	8.51e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2A—schizophrenia	1.04e-05	8.51e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR1A—schizophrenia	1.04e-05	8.48e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NPS—schizophrenia	1.03e-05	8.38e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2A—schizophrenia	1.03e-05	8.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NPS—schizophrenia	1.02e-05	8.35e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR1A—schizophrenia	1.02e-05	8.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.02e-05	8.31e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD2—schizophrenia	1.02e-05	8.31e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR7—schizophrenia	1.02e-05	8.31e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NPS—schizophrenia	1.01e-05	8.22e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GAPDH—schizophrenia	1.01e-05	8.22e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2C—schizophrenia	1.01e-05	8.22e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD1—schizophrenia	1.01e-05	8.22e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD1—schizophrenia	1e-05	8.19e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2C—schizophrenia	1e-05	8.19e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CLOCK—schizophrenia	9.99e-06	8.15e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—schizophrenia	9.97e-06	8.13e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2C—schizophrenia	9.89e-06	8.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD1—schizophrenia	9.89e-06	8.06e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	9.85e-06	8.04e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK2—schizophrenia	9.8e-06	7.99e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK2—schizophrenia	9.77e-06	7.97e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD3—schizophrenia	9.76e-06	7.96e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPH2—schizophrenia	9.74e-06	7.94e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CACNB2—schizophrenia	9.74e-06	7.94e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD3—schizophrenia	9.73e-06	7.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK2—schizophrenia	9.62e-06	7.84e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRL—schizophrenia	9.62e-06	7.84e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIP4K2A—schizophrenia	9.58e-06	7.82e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—DPYD—schizophrenia	9.58e-06	7.81e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD3—schizophrenia	9.57e-06	7.81e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD4—schizophrenia	9.47e-06	7.73e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD4—schizophrenia	9.44e-06	7.7e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD4—schizophrenia	9.29e-06	7.58e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GAPDH—schizophrenia	9.27e-06	7.56e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CLOCK—schizophrenia	9.19e-06	7.49e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CNR1—schizophrenia	9.04e-06	7.38e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CNR1—schizophrenia	9.02e-06	7.35e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—S100B—schizophrenia	8.96e-06	7.31e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPH2—schizophrenia	8.95e-06	7.3e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CACNB2—schizophrenia	8.95e-06	7.3e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CACNA1C—schizophrenia	8.9e-06	7.26e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CNR1—schizophrenia	8.88e-06	7.24e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR7—schizophrenia	8.82e-06	7.2e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD2—schizophrenia	8.82e-06	7.2e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—DPYD—schizophrenia	8.81e-06	7.19e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD2—schizophrenia	8.8e-06	7.17e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR7—schizophrenia	8.8e-06	7.17e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3C2A—schizophrenia	8.68e-06	7.08e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP26B1—schizophrenia	8.67e-06	7.07e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR7—schizophrenia	8.66e-06	7.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD2—schizophrenia	8.66e-06	7.06e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ERBB4—schizophrenia	8.57e-06	6.99e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRL—schizophrenia	8.33e-06	6.8e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRL—schizophrenia	8.31e-06	6.78e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CACNA1C—schizophrenia	8.19e-06	6.68e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRL—schizophrenia	8.18e-06	6.67e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	8.06e-06	6.57e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3C2A—schizophrenia	7.98e-06	6.51e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NRG1—schizophrenia	7.91e-06	6.45e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MEF2C—schizophrenia	7.84e-06	6.39e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2D6—schizophrenia	7.78e-06	6.35e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SNAP25—schizophrenia	7.78e-06	6.35e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—S100B—schizophrenia	7.77e-06	6.33e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—S100B—schizophrenia	7.74e-06	6.31e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCLM—schizophrenia	7.72e-06	6.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPH1—schizophrenia	7.72e-06	6.3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—S100B—schizophrenia	7.62e-06	6.22e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	7.58e-06	6.18e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ERBB4—schizophrenia	7.43e-06	6.06e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ERBB3—schizophrenia	7.41e-06	6.04e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ERBB4—schizophrenia	7.4e-06	6.04e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ERBB4—schizophrenia	7.29e-06	5.94e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PRKD1—schizophrenia	7.26e-06	5.92e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SNAP25—schizophrenia	7.16e-06	5.84e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—schizophrenia	7.13e-06	5.82e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP1A2—schizophrenia	7.04e-06	5.74e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	6.98e-06	5.7e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PLA2G4A—schizophrenia	6.96e-06	5.68e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TH—schizophrenia	6.94e-06	5.66e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NRG1—schizophrenia	6.85e-06	5.59e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PLA2G4A—schizophrenia	6.85e-06	5.59e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NRG1—schizophrenia	6.83e-06	5.57e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MEF2C—schizophrenia	6.79e-06	5.54e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MEF2C—schizophrenia	6.77e-06	5.52e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NRG1—schizophrenia	6.73e-06	5.49e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MEF2C—schizophrenia	6.67e-06	5.44e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—schizophrenia	6.63e-06	5.41e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—YWHAZ—schizophrenia	6.57e-06	5.36e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOA1—schizophrenia	6.55e-06	5.35e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—YWHAZ—schizophrenia	6.54e-06	5.34e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1A2—schizophrenia	6.47e-06	5.28e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—YWHAZ—schizophrenia	6.44e-06	5.26e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ERBB3—schizophrenia	6.42e-06	5.24e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ERBB3—schizophrenia	6.4e-06	5.22e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TH—schizophrenia	6.38e-06	5.2e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ESR1—schizophrenia	6.33e-06	5.16e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ERBB3—schizophrenia	6.3e-06	5.14e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—schizophrenia	6.18e-06	5.04e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—schizophrenia	6.16e-06	5.02e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—schizophrenia	6.06e-06	4.95e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GAPDH—schizophrenia	6.06e-06	4.94e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CLOCK—schizophrenia	6.01e-06	4.9e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—COMT—schizophrenia	5.9e-06	4.81e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTP1—schizophrenia	5.87e-06	4.79e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MAOA—schizophrenia	5.86e-06	4.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPH2—schizophrenia	5.85e-06	4.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNB2—schizophrenia	5.85e-06	4.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DPYD—schizophrenia	5.76e-06	4.7e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—schizophrenia	5.75e-06	4.69e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GSK3B—schizophrenia	5.74e-06	4.68e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—schizophrenia	5.73e-06	4.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—schizophrenia	5.68e-06	4.63e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.68e-06	4.63e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—schizophrenia	5.66e-06	4.62e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—schizophrenia	5.64e-06	4.6e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—schizophrenia	5.57e-06	4.55e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCB1—schizophrenia	5.56e-06	4.53e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—schizophrenia	5.49e-06	4.47e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—schizophrenia	5.47e-06	4.46e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—COMT—schizophrenia	5.42e-06	4.43e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTP1—schizophrenia	5.4e-06	4.4e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PLA2G4A—schizophrenia	5.39e-06	4.4e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—schizophrenia	5.39e-06	4.4e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MAOA—schizophrenia	5.39e-06	4.39e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—schizophrenia	5.38e-06	4.39e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNA1C—schizophrenia	5.35e-06	4.37e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3C2A—schizophrenia	5.22e-06	4.26e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCB1—schizophrenia	5.11e-06	4.17e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GSK3B—schizophrenia	4.98e-06	4.06e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—schizophrenia	4.96e-06	4.05e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PLA2G4A—schizophrenia	4.96e-06	4.05e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GSK3B—schizophrenia	4.96e-06	4.05e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GSK3B—schizophrenia	4.88e-06	3.98e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—schizophrenia	4.77e-06	3.89e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2D6—schizophrenia	4.68e-06	3.82e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SNAP25—schizophrenia	4.68e-06	3.82e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—schizophrenia	4.44e-06	3.62e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—schizophrenia	4.39e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—schizophrenia	4.38e-06	3.58e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	4.26e-06	3.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1A2—schizophrenia	4.23e-06	3.45e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TH—schizophrenia	4.17e-06	3.4e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—schizophrenia	4.08e-06	3.33e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—schizophrenia	4.04e-06	3.29e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—schizophrenia	3.87e-06	3.15e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EP300—schizophrenia	3.78e-06	3.08e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—schizophrenia	3.69e-06	3.01e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—schizophrenia	3.68e-06	3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—schizophrenia	3.62e-06	2.95e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—COMT—schizophrenia	3.55e-06	2.89e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTP1—schizophrenia	3.53e-06	2.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MAOA—schizophrenia	3.52e-06	2.87e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—schizophrenia	3.35e-06	2.73e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCB1—schizophrenia	3.34e-06	2.73e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—schizophrenia	3.34e-06	2.72e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—schizophrenia	3.29e-06	2.68e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EP300—schizophrenia	3.27e-06	2.67e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EP300—schizophrenia	3.26e-06	2.66e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—schizophrenia	3.24e-06	2.65e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G4A—schizophrenia	3.24e-06	2.65e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EP300—schizophrenia	3.21e-06	2.62e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—schizophrenia	2.87e-06	2.34e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—schizophrenia	2.7e-06	2.21e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—schizophrenia	2.67e-06	2.18e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—schizophrenia	2.64e-06	2.15e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—EP300—schizophrenia	2.53e-06	2.06e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—schizophrenia	2.34e-06	1.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—schizophrenia	2.34e-06	1.91e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—EP300—schizophrenia	2.33e-06	1.9e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—schizophrenia	2.3e-06	1.88e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—schizophrenia	2.28e-06	1.86e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—schizophrenia	1.98e-06	1.61e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—schizophrenia	1.97e-06	1.61e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—schizophrenia	1.94e-06	1.58e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—schizophrenia	1.53e-06	1.25e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—EP300—schizophrenia	1.52e-06	1.24e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—schizophrenia	1.41e-06	1.15e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—schizophrenia	9.19e-07	7.5e-06	CbGpPWpGaD
